Bei Akademie registrieren
EIPICO stock, Egyptian Exchange

EIPICO stock closes at 98.40 Egyptian pounds on the EGX

Published on 11/05/2026 at 00:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
EIPICO stock was last reported at the Egyptian Exchange after Tuesday's session. The company operates across Egypt's pharmaceutical market and has been listed since 1995.

Company profile and exchange context

  • EIPICO is an Egyptian pharmaceutical manufacturer established in 1980 and listed on the Egyptian Exchange since 1995.
  • The company reported six decades of consecutive profitable reporting periods from 2013 through 2026 in its exchange record.
EIPICO stock, Egyptian Exchange, pharmaceuticals, PHAR, Egyptian equities, Illustration mit AI erstellt.
EIPICO stock, Egyptian Exchange, pharmaceuticals, PHAR, Egyptian equities, Illustration mit AI erstellt.

Egyptian International Pharmaceutical Industries, known as EIPICO, closed at 98.40 Egyptian pounds in the Tuesday, November 3, 2026 session on the Egyptian Exchange, according to ESTHMR. The close gives investors a dated reference point for the latest completed exchange session.

Profitability remains central

ESTHMR's exchange record shows 63 consecutive profitable reporting periods from 2013 through 2026. Annual net results ranged from 330 million Egyptian pounds in fiscal 2013 to 1.458 billion Egyptian pounds in fiscal 2025, according to the same company record.

The latest filings listed on the page include consolidated and standalone financial results for the period from January 1 through June 30, 2026. The record also includes a board and shareholder-structure disclosure dated October 14, 2026.

Established Egyptian manufacturer

EIPICO is a pharmaceutical company established in December 1980 and based in 10th of Ramadan, Egypt. It develops and manufactures medicines for the Egyptian market and operates through holdings including Egyptian International Company for Ampoules and EIPICO Tech for Medicines. Its listed Egyptian peers include GlaxoSmithKline S.A.E., Ibnsina Pharma and Tenth of Ramadan Pharmaceutical Industries and Diagnostic-Rameda, placing EIPICO among established companies in the country's pharmaceutical sector.

EIPICO at a glance

  • Company: Egyptian International Pharmaceutical Industries
  • Trading venue: Egyptian Exchange
  • Latest close: 98.40 Egyptian pounds on Tuesday, November 3, 2026
  • Market value: 16.61 billion Egyptian pounds
  • One-year closing range: 69.64 to 160.18 Egyptian pounds
  • Sector: Health Care and Pharmaceuticals

For broader market context, investors can follow Current market reports.

Disclaimer...
en | boerse | 70459994 |